Senior Microbiome Scientist / June, 2023 — Present

• Consult with clients to advise the best approach for their microbiome and metabolomics study design, sample collection and storage, sequencing and metabolomics methods, and bioinformatics and statistical analysis • Create custom analyses and reports helping clients understand their data • Manage and review scientific newsletters and blogs • Develop and test new methods for innovative data analysis • Promoted to senior microbiome scientist to lead custom project analysis and integration of new analysis methods and pipelines • Managed the bioinformatics team in sequencing production and project delivery

Microbiome Scientist / August, 2021 — June, 2023

• Identified the impact of microbiome-based therapeutics on subjects with Clostridioides difficile infection through analysis of micrbial community, functional, and metabolomics data • Established new methodologies for integration of complex microbial compositional, functional, and metabolomics data in the programming language R • Managed and developed relationships with microbiome analysis collaborators to drive high-quality and novel analysis methods and product development • Presented at least one oral talk per year at a national conference on the impact of biotherapeutics on the microbiome

Microbiome Consultant / January, 2023 — Present

• Meet with customers (individuals and clinicians) to explain their gut microbiome test results • Provide a basic understanding of the gut microbiome and its importance in health along with individualized interpretation of results and recommendations of over-the-counter interventions that may help (such as the use of specific pre- and probiotics or dietary recommendations)

Microbiome Analysis Scientist / June, 2019 — August, 2021

• Identified the impact of microbiome-based therapeutics on subjects with Clostridioides difficile infection through analysis of micrbial community, functional, and metabolomics data • Established new methodologies for integration of complex microbial compositional, functional, and metabolomics data in the programming language R • Managed and developed relationships with microbiome analysis collaborators to drive high-quality and novel analysis methods and product development • Presented at least one oral talk per year at a national conference on the impact of biotherapeutics on the microbiome

Postdoctoral Research Fellow / October, 2016 — June, 2019

• Investigated the role of the vaginal and uterine microbiota in development and treatment of ovarian and endometrial cancer using human, mouse, and cell models • Determined the role of metformin in altering the gut microbiota during chemotherapy treatment for ovarian cancer in a patient-derived xenograft mouse model • Analyzed reproductive tract microbiota from patients with endometrial cancer to identify early vaginal biomarkers of disease using R • Developed an invasion assay to determine pathogenicity of specific members of the microbiota in endometrial and ovarian cancer. • Carried out complementary in vitro tissue culture work to determine the role of specific microbial products (bile acids and short-chain fatty acids) in killing of tumor cells.